[Retracted] Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure

Table 3

The serum levels of IL-13, TGF-β1, and periostin according to different NYHA classifications of AHF.

Item	AHF-II (n = 33)	AHF-III (n = 28)	AHF-IV (n = 22)
LVEF (%)	46.08 ± 2.77	41.12 ± 4.54	38.49 ± 3.45^#	<0.05
IL-13 (pg/mL)	4.89 ± 0.21	5.16 ± 0.25	5.44 ± 0.35^#	<0.001
TGF-β1 (μg/L)	53.38 ± 5.94	59.66 ± 6.34	66.23 ± 5.39^#	<0.001
Periostin (ng/L)	78.83 ± 11.01	91.58 ± 9.46	102.07 ±7.28^#	<0.001

Note: LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic dimension; LVEDV, left ventricle end diastolic volume; LVMI, left ventricular mass index; compared to the AHF-II group, and ^# compared to the AHF-III group.